Friday, March 5, 2021
Home Biotech News Diabetes

Diabetes

    Latest
    Cyclophilin, Biotech Stock Review

    Adding Hepion Pharma (HEPA) $1.73 to Watch List.

    Biotech News Editor / Curator -
    Adding Hepion Pharma ($1.73) to Watch List. Oh My. What Did We Find Here? Oh my…and Oh boy....
    Hepion, Biotech Stock Review

    Hepion Pharma (HEPA): News Archive

    CoronaVirus Editor / Curator -
    UPDATED CONTINUOUSLY.. 12/31/2020: News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10. 12/23/2020: Remember...
    roland rick perry

    Can This Diabetes Drug Make you Smarter?

    Biotech News Editor / Curator -
    OKAY, maybe not make you smarter, but a new study out today says it may delay the onset of dementia - so...

    Latest article

    Wall Street Pounces on Hydroponics.

    All News Editor / Curator -
    Indoor Growing & Hydroponics Outperform Both the Market and Marijuana Sector. Investor attention is...

    Another Look at the Snowflake (SNOW) Mega IPO.

    Internet News Editor / Curator -
    We haven't looked at Snowflake (SNOW) since its amazing IPO debut. It was priced at $120 and opened for trading at $245...
    Citius

    Wall Street Showing Love. Hepion Pharma (HEPA), Citius Pharma (CTXR) Raise $166 Million.

    Biotech News Editor / Curator -
    Hepion (HEPA) Banked $88 Million Yesterday, Citius (CTXR) Banks $78 Million Today. We're beginning to believe (and...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: roland@institutionalanalyst.com
    © Managed by Revelers.IO Media Group Inc.